Cargando…

Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy

BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Jianfeng, Zu, Xiangyang, Wang, Xiao, Li, Jinghua, Fan, Dandan, Shi, Yupeng, Xia, Qingchun, Cheng, Jingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550217/
https://www.ncbi.nlm.nih.gov/pubmed/33116495
http://dx.doi.org/10.2147/IJN.S267321
_version_ 1783592928549011456
author Bao, Jianfeng
Zu, Xiangyang
Wang, Xiao
Li, Jinghua
Fan, Dandan
Shi, Yupeng
Xia, Qingchun
Cheng, Jingliang
author_facet Bao, Jianfeng
Zu, Xiangyang
Wang, Xiao
Li, Jinghua
Fan, Dandan
Shi, Yupeng
Xia, Qingchun
Cheng, Jingliang
author_sort Bao, Jianfeng
collection PubMed
description BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organic ligand of the NMOF for cancer treatments and merely reported limited theranostic functions, which may not be optimized. As a highly designable and easily functionalized material, prospective rational design offers a powerful way to extract the maximum benefit from NMOF for cancer theranostic applications. MATERIALS AND METHODS: A NMOF based on hafnium (Hf) cluster and Mn(III)-porphyrin ligand was rational designed and synthesized as a high-performance multifunctional theranostic agent. The folic acid (FA) was modified on the NMOF surface to enhance the cancer targeting efficacy. The proposed “all-in-one” FA-Hf-Mn-NMOF (fHMNM) was characterized and identified using various analytical techniques. Then, in vitro and in vivo studies were performed to further explore the effects of fHMNM both as the magnetic resonance imaging (MRI)/computed tomography (CT)/photoacoustic imaging (PAI) contrast agent and as the photothermal therapy (PTT)/radiotherapy (RT) agent. RESULTS: A tumour targeting multifunctional fHMNM was successfully synthesized with high performance for MRI/CT/PAI enhancements and image-guided PTT/RT synergistic therapy properties. Compared with the current clinical CT and MR contrast agents, the X-ray attenuation and T(1) relaxation rate of this integrated nanosystem increased 1.7-fold and 3–5-fold, respectively. More importantly, the catalase-like Mn(III)-porphyrin ligand can decompose H(2)O(2) into O(2) in tumour microenvironments to improve the synergistic treatment efficiency of PTT and RT. Significant tumour growth inhibition was achieved in mouse cancer models without obvious damage to the other organs. CONCLUSION: This work highlights the potential of fHMNM as an easily designable material for biomedical applications, could be an effective tool for in vivo detection and subsequent treatment of tumour.
format Online
Article
Text
id pubmed-7550217
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75502172020-10-27 Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy Bao, Jianfeng Zu, Xiangyang Wang, Xiao Li, Jinghua Fan, Dandan Shi, Yupeng Xia, Qingchun Cheng, Jingliang Int J Nanomedicine Original Research BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organic ligand of the NMOF for cancer treatments and merely reported limited theranostic functions, which may not be optimized. As a highly designable and easily functionalized material, prospective rational design offers a powerful way to extract the maximum benefit from NMOF for cancer theranostic applications. MATERIALS AND METHODS: A NMOF based on hafnium (Hf) cluster and Mn(III)-porphyrin ligand was rational designed and synthesized as a high-performance multifunctional theranostic agent. The folic acid (FA) was modified on the NMOF surface to enhance the cancer targeting efficacy. The proposed “all-in-one” FA-Hf-Mn-NMOF (fHMNM) was characterized and identified using various analytical techniques. Then, in vitro and in vivo studies were performed to further explore the effects of fHMNM both as the magnetic resonance imaging (MRI)/computed tomography (CT)/photoacoustic imaging (PAI) contrast agent and as the photothermal therapy (PTT)/radiotherapy (RT) agent. RESULTS: A tumour targeting multifunctional fHMNM was successfully synthesized with high performance for MRI/CT/PAI enhancements and image-guided PTT/RT synergistic therapy properties. Compared with the current clinical CT and MR contrast agents, the X-ray attenuation and T(1) relaxation rate of this integrated nanosystem increased 1.7-fold and 3–5-fold, respectively. More importantly, the catalase-like Mn(III)-porphyrin ligand can decompose H(2)O(2) into O(2) in tumour microenvironments to improve the synergistic treatment efficiency of PTT and RT. Significant tumour growth inhibition was achieved in mouse cancer models without obvious damage to the other organs. CONCLUSION: This work highlights the potential of fHMNM as an easily designable material for biomedical applications, could be an effective tool for in vivo detection and subsequent treatment of tumour. Dove 2020-10-08 /pmc/articles/PMC7550217/ /pubmed/33116495 http://dx.doi.org/10.2147/IJN.S267321 Text en © 2020 Bao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bao, Jianfeng
Zu, Xiangyang
Wang, Xiao
Li, Jinghua
Fan, Dandan
Shi, Yupeng
Xia, Qingchun
Cheng, Jingliang
Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title_full Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title_fullStr Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title_full_unstemmed Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title_short Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
title_sort multifunctional hf/mn-tcpp metal-organic framework nanoparticles for triple-modality imaging-guided ptt/rt synergistic cancer therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550217/
https://www.ncbi.nlm.nih.gov/pubmed/33116495
http://dx.doi.org/10.2147/IJN.S267321
work_keys_str_mv AT baojianfeng multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT zuxiangyang multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT wangxiao multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT lijinghua multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT fandandan multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT shiyupeng multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT xiaqingchun multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy
AT chengjingliang multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy